BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GlobalData Release: Poor Healthcare Policies and Infrastructure, but India's Pharma Market Continues to Boom


8/20/2012 9:53:02 AM

LONDON, UK (GlobalData), 20 August 2012 - India has numerous healthcare problems, ranging from inadequate policy monitoring to the widespread lack of health insurance, but a potentially huge, unsaturated market will see the country’s pharmaceutical industry continue to expand rapidly in the coming years, predicts the latest study by market analysts GlobalData.

According to the new report*, India’s pharmaceutical market had a 2011 valuation of $15 billion in 2011, but this is expected to rocket to $54 billion by 2020, climbing at a Compound Annual Growth Rate (CAGR) of 15.4% during this period.

A substantial portion of India’s pharmaceutical industry growth can be attributed to its export sector, which had a 2010 value of $8.8 billion – 40% of the country’s pharmaceutical industry turnover.

India’s generic drug sector is by far the dominant force in the country’s pharmaceutical industry, accounting for approximately 95% of revenue. Furthermore, 80% of these generics were produced by domestic firms. GlobalData’s report states that this already booming market has the potential for huge further expansion thanks to India’s considerable population and high number of leading drugs going off-patent every year.

But despite this pharmaceutical prosperity, India faces several sizeable healthcare challenges. Spending on healthcare increased gradually to 4.2% of Gross Domestic Product (GDP) in 2010, but remained below that of other emerging economies such as Brazil, Russia, China and South Africa.

India’s healthcare infrastructure is also insufficiently prepared to meet growing demand. Currently there are only 0.9 beds per 1,000 people, in addition to a lack of qualified staff and poor management.

The country’s poor healthcare infrastructure has corresponding problems. Health coverage is low across the country, with 80% of the population not covered by any form of insurance in 2010. The relatively low level of urbanization in India is a major contributing factor to this low insured population figure as healthcare infrastructure in rural areas is particularly inadequate.

*Healthcare, Regulatory and Reimbursement Landscape - India

This report is an essential source of information and analysis on India’s healthcare, regulatory and reimbursement landscape.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.

-ABOUT GLOBALDATA-

GlobalData is a leading global business intelligence provider offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.

For more information, please contact our Press Office on +44 (0)1204 543 528 or at pr@globaldata.com



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->